Phathom Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $39,503 | $28,519 | $29,664 | $16,352 |
Gross Profit | 34,465 | 24,795 | 25,849 | 13,996 |
EBITDA | -58,120 | -78,863 | -55,665 | -66,902 |
EBIT | -58,292 | -79,040 | -55,858 | -67,093 |
Net Income | -75,810 | -94,316 | -74,451 | -85,577 |
Net Change In Cash | 39,503 | 28,519 | 29,664 | 16,352 |
Free Cash Flow | -62,729 | -84,948 | -63,461 | -63,487 |
Cash | 149,569 | 212,315 | 297,263 | 334,678 |
Basic Shares | 72,466 | 71,969 | 71,045 | 64,628 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $55,252 | $682 | $0 | $0 |
Gross Profit | 47,279 | 515 | -620 | -521 |
EBITDA | -261,522 | -159,049 | -171,820 | -134,559 |
EBIT | -262,317 | -159,624 | -172,440 | -135,080 |
Net Income | -334,326 | -201,592 | -223,006 | -148,094 |
Net Change In Cash | 55,252 | 682 | 0 | 0 |
Cost of Revenue | -104,237 | |||
Free Cash Flow | -266,905 | -139,214 | -147,571 | -148,945 |
Cash | 297,263 | 381,393 | 155,385 | 183,259 |
Basic Shares | 63,176 | 51,289 | 39,118 | 37,002 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.79 |
2025-03-31 | -$1.07 |
2024-12-31 | -$1.05 |
